{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:57:23Z","timestamp":1787684243703,"version":"build-2784847793"},"reference-count":35,"publisher":"Baishideng Publishing Group Inc.","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastroenterol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Although the relationship between somatic DNA polymerase epsilon (POLE)  exonuclease domain mutations (EDMs) and colorectal cancer (CRC) is well established, the role of POLE  non-EDMs in CRC remains unclear.<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To identify POLE  non-EDMs and EDMs in CRC, and to determine their associations with accompanying mutations and microsatellite instability (MSI).<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>In this retrospective study, next-generation sequencing was performed using a targeted colon cancer panel (Qiagen, DHS-003Z) on 356 CRC patients. Of these, 191 patients were found to carry POLE  mutations. For these patients, MSI status was assessed using both real-time PCR (EasyPGX\u00ae Ready MSI kit) and immunohistochemistry, and accompanying somatic mutations were investigated.<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>POLE  mutations were identified in 53.65% of the CRC patients. Among the POLE -mutant patients, 87.96% were classified as pMMR (MSI-L), and 12.04% as dMMR (MSI-H). The most frequently observed POLE  non-EDM variant was exon 34 c.4337_4338delTG p.V1446fs*3. The POLE  EDMs were present in exon 14, with two specific variants p.Y458F (0.52%) and p.Y468N (0.52%). The most common pathogenic variants accompanying the POLE  mutations were in MLH3, MSH3, KRAS, PIK3CA , and BRAF  genes. POLE  mutations were associated with a high mutational burden and MSI in CRC, particularly in the dMMR phenotype. This association suggests that POLE  mutations may serve as important biomarkers for understanding the genetic profile of the disease and may be used in the clinical management of CRC.<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>POLE  mutations, especially non-EDMs, are frequent in MSI-L CRC and often co-occur with MLH3, MSH3, KRAS, PIK3CA , and BRAF,  highlighting their potential role in tumor biology and as biomarkers for personalized treatment. Functional validation and multicenter studies are needed.<\/jats:p>","DOI":"10.3748\/wjg.v31.i44.112524","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:20:43Z","timestamp":1764235243000},"source":"Crossref","is-referenced-by-count":4,"title":["DNA polymerase epsilon-mutant colorectal cancers: Insights into non-exonuclease domain mutation variants, microsatellite instability status, and co-mutation profiles"],"prefix":"10.3748","volume":"31","author":[{"given":"Ismail","family":"Taskiran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Orenay-Boyacioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olcay","family":"Boyacioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Halil","family":"Erdogdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"Culhaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Meteoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02039"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02422-1"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01104-7"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1368"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.36922\/td.3659"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2022.101983"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.963964"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.305"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/path.4185"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0356"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008572"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae098"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2021.03.002"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/185326"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30014-0"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00267"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15810"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.5689"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-015-9803-2"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2503"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu058"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.75"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00438-023-02000-w"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2344"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1245"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00977.x"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2008.080031"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0094-7"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0201-OA"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5997"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.06.047"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1943-3"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.048"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/srep39348"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104409"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v31\/i44\/112524.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v31\/i44\/112524.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:20:56Z","timestamp":1764235256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v31\/i44\/112524.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":35,"journal-issue":{"issue":"44"},"alternative-id":["112524"],"URL":"https:\/\/doi.org\/10.3748\/wjg.v31.i44.112524","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}